Fig. 1From: PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinomaRepresentative images and comparisons of the tumor burden in the (A) lung and (B) parietal peritoneum of early-stage mRCC model mice treated with the JX-594 and PD-1 inhibitor combination, a PD-1 inhibitor only, or the PD-1 and CTLA-4 inhibitor combinationBack to article page